Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    November 2022
  1. CHAI GS, Wu JJ, Gong J, Zhou JL, et al
    Activation of beta2-adrenergic Receptor Ameliorates Amyloid-beta-induced Mitophagy Defects and Tau Pathology in Mice.
    Neuroscience. 2022;505:34-50.
    PubMed     Abstract available


  2. ANAND S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, et al
    Resolvins lipid mediators: Potential therapeutic targets in Alzheimer and Parkinson disease.
    Neuroscience. 2022 Nov 10. pii: S0306-4522(22)00546.
    PubMed     Abstract available


  3. YANG L, Nao J
    Focus on Alzheimer's disease: the role of fibroblast growth factor 21 and autophagy.
    Neuroscience. 2022 Nov 10. pii: S0306-4522(22)00548.
    PubMed     Abstract available


  4. RYCHLIK M, Starowicz G, Starnowska-Sokol J, Mlyniec K, et al
    The Zinc-sensing Receptor (GPR39) Modulates Declarative Memory and Age-related Hippocampal Gene Expression in Male Mice.
    Neuroscience. 2022;503:1-16.
    PubMed     Abstract available


    September 2022
  5. LIN L, Ni L, Wang X, Sheng C, et al
    Longitudinal cognitive change and duration of Alzheimer's disease stages in relation to cognitive reserve.
    Neuroscience. 2022 Sep 28. pii: S0306-4522(22)00487.
    PubMed     Abstract available


  6. ZHAI Z, Xie D, Qin T, Zhong Y, et al
    Effect and Mechanism of Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic review and Meta-analysis.
    Neuroscience. 2022 Sep 15. pii: S0306-4522(22)00466.
    PubMed     Abstract available


    August 2022
  7. TORRES-FLORES M, Pena-Ortega F
    Amyloid Beta Alters Prefrontal-dependent Functions Along with its Excitability and Synaptic Plasticity in Male Rats.
    Neuroscience. 2022;498:260-279.
    PubMed     Abstract available


  8. UNGERLEIDER K, Beck JA, Lissa D, Joruiz S, et al
    Delta133p53alpha Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity.
    Neuroscience. 2022;498:190-202.
    PubMed     Abstract available


  9. BIANCHIN MM, Snow Z
    Primary Microglia Dysfunction or Microgliopathy: A Cause of Dementias and Other Neurological or Psychiatric Disorders.
    Neuroscience. 2022;497:324-339.
    PubMed     Abstract available


  10. PATTA PC, de Oliveira EMN, Goulart ACF, Zaluski AB, et al
    Nanoscale Structural Characterization and Impact on Long-term memory of Amyloid-beta42 Oligomeric forms in Zebrafish.
    Neuroscience. 2022;497:271-281.
    PubMed     Abstract available


  11. ZHU Y, Gao M, Huang H, Gao SH, et al
    p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.
    Neuroscience. 2022;496:27-37.
    PubMed     Abstract available


    June 2022
  12. WU Y, Wu X, Gao L, Yan Y, et al
    Abnormal functional connectivity of thalamic subdivisions in alzheimer's disease: A functional magnetic resonance imaging study.
    Neuroscience. 2022 Jun 8. pii: S0306-4522(22)00291.
    PubMed     Abstract available


    May 2022
  13. GUZMAN-RAMOS K, Osorio-Gomez D, Bermudez-Rattoni F
    Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis.
    Neuroscience. 2022 May 30. pii: S0306-4522(22)00271.
    PubMed     Abstract available


  14. LIANG F, Sun F, He B, Wang J, et al
    Treadmill Exercise Promotes Microglial beta-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
    Neuroscience. 2022;491:122-133.
    PubMed     Abstract available


  15. QU W, Canoll P, Hargus G
    Molecular insights into cell type-specific roles in alzheimer's disease: human induced pluripotent stem cell-based disease modeling.
    Neuroscience. 2022 May 12. pii: S0306-4522(22)00235.
    PubMed     Abstract available


    April 2022
  16. ZHANG F, Pan B, Shao P, Liu P, et al
    A Single Model Deep Learning Approach for Alzheimer's Disease Diagnosis.
    Neuroscience. 2022 Apr 7. pii: S0306-4522(22)00149.
    PubMed     Abstract available


    February 2022
  17. CLARK I
    Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease.
    Neuroscience. 2022;484:139.
    PubMed    


  18. MACKENZIE JL, Ivanova N, Nell HJ, Giordano CR, et al
    Microglial inflammation and cognitive dysfunction in comorbid rat models of striatal ischemic stroke and alzheimer's disease: effects of antioxidant catalase-SKL on behavioral and cellular pathology.
    Neuroscience. 2022 Feb 3. pii: S0306-4522(22)00047.
    PubMed     Abstract available


    January 2022
  19. ASIH PR, Stefanoska K, Prikas E, Ittner A, et al
    High level forebrain expression of active tau kinase p38gamma exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice.
    Neuroscience. 2022 Jan 11. pii: S0306-4522(22)00012.
    PubMed     Abstract available


  20. HORTA-LOPEZ PH, Mendoza-Franco G, Rodriguez-Cruz F, Torres-Cruz FM, et al
    Association of alpha-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain.
    Neuroscience. 2022 Jan 8. pii: S0306-4522(22)00002.
    PubMed     Abstract available


    December 2021
  21. HAN H, Li X, Gan JQ, Yu H, et al
    Biomarkers derived from alterations in overlapping community structure of resting-state brain functional networks for detecting Alzheimer's disease.
    Neuroscience. 2021 Dec 29. pii: S0306-4522(21)00662.
    PubMed     Abstract available


  22. LI Y, Fan H, Ni M, Zhang W, et al
    Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-kappaB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation.
    Neuroscience. 2021 Dec 22. pii: S0306-4522(21)00551.
    PubMed     Abstract available


  23. AHMADI A, Gispert JD, Navarro A, Vilor-Tejedor N, et al
    Single-cell Transcriptional Changes in Neurodegenerative Diseases.
    Neuroscience. 2021;479:192-205.
    PubMed     Abstract available


    November 2021
  24. DUNCAN MJ, Guerriero LE, Kohler K, Beechem LE, et al
    Chronic fragmentation of the daily sleep-wake rhythm increases amyloid-beta levels and neuroinflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Neuroscience. 2021 Nov 29. pii: S0306-4522(21)00609.
    PubMed     Abstract available


  25. CHINNATHAMBI S, Gorantla NV
    Implications of Valosin-containing Protein in Promoting Autophagy to Prevent Tau Aggregation.
    Neuroscience. 2021;476:125-134.
    PubMed     Abstract available


    October 2021
  26. CHAGNOT A, Barnes SR, Montagne A
    Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.
    Neuroscience. 2021;474:14-29.
    PubMed     Abstract available


    August 2021
  27. ZHANG W, Xiong BR, Zhang LQ, Huang X, et al
    The Role of the GABAergic System in Diseases of the Central Nervous System.
    Neuroscience. 2021;470:88-99.
    PubMed     Abstract available


    June 2021
  28. MANSOUR HM, Fawzy HM, El-Khatib AS, Khattab MM, et al
    Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.
    Neuroscience. 2021 Jun 15. pii: S0306-4522(21)00305.
    PubMed     Abstract available


    May 2021
  29. ALBUS A, Kronimus Y, Neumann S, Vidovic N, et al
    Effects of a Multimerized Recombinant Autoantibody Against Amyloid-beta.
    Neuroscience. 2021;463:355-369.
    PubMed     Abstract available


  30. GUIX FX
    Enhancing Anti-Abeta Properties of Recombinant Autoantibodies.
    Neuroscience. 2021;463:354.
    PubMed    


    April 2021
  31. JUNG H, Yi D, Soo Byun M, Ho Lee J, et al
    Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease.
    Neuroscience. 2021 Apr 15. pii: S0306-4522(21)00179.
    PubMed     Abstract available


  32. NAZANIN HAJJARI S, Sadigh-Eteghad S, Shanehbandi D, Teimourian S, et al
    MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's disease.
    Neuroscience. 2021 Apr 6. pii: S0306-4522(21)00163.
    PubMed     Abstract available


    March 2021
  33. ZENG L, Zhang D, Liu Q, Zhang J, et al
    Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Abeta42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus.
    Neuroscience. 2021;458:141-152.
    PubMed     Abstract available


  34. LEDEZMA C, Coria-Lucero C, Delsouc MB, Casais M, et al
    Effect of an Intracerebroventricular Injection of Aggregated Beta-amyloid (1-42) on Daily Rhythms of Oxidative Stress Parameters in the Prefrontal Cortex.
    Neuroscience. 2021;458:99-107.
    PubMed     Abstract available


    February 2021
  35. WALKER CK, Greathouse KM, Boros BD, Poovey EH, et al
    Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
    Neuroscience. 2021;455:195-211.
    PubMed     Abstract available


  36. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    Corrigendum to "Inhibitor Kappa B Kinase beta, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer's Disease Model" [Neuroscience 452C (2021) 1-12].
    Neuroscience. 2021 Feb 5. pii: S0306-4522(21)00014.
    PubMed    


  37. MONTEIRO-FERNANDES D, Sousa N, Almeida OFX, Sotiropoulos I, et al
    Sex Hormone Depletion Augments Glucocorticoid Induction of Tau Hyperphosphorylation in Male Rat Brain.
    Neuroscience. 2021;454:140-150.
    PubMed     Abstract available


    January 2021
  38. MEHMOOD A, Yang S, Feng Z, Wang M, et al
    A Transfer Learning Approach for Early Diagnosis of Alzheimer's Disease on MRI Images.
    Neuroscience. 2021 Jan 16. pii: S0306-4522(21)00007.
    PubMed     Abstract available


  39. PEAK SL, Gracia L, Lora G, Jinwal UK, et al
    Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Neuroscience. 2021;453:312-323.
    PubMed     Abstract available


    November 2020
  40. AVILA J, Perry G
    A multilevel view of the development of Alzheimer's Disease.
    Neuroscience. 2020 Nov 24. pii: S0306-4522(20)30731.
    PubMed     Abstract available


  41. DOBRI AM, Dudau M, Enciu AM, Hinescu ME, et al
    CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting.
    Neuroscience. 2020 Nov 17. pii: S0306-4522(20)30719.
    PubMed     Abstract available


  42. LUO Y, Sun T, Ma C, Zhang X, et al
    Alterations of Brain Networks in Alzheimer's Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30684.
    PubMed     Abstract available


  43. ZHOU Y, Ge Y, Liu Q, Li YX, et al
    LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30688.
    PubMed     Abstract available


    October 2020
  44. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    IKKbeta, modulated by DJ-1/p-VHL, reduces phosphorylated Tau (p-Tau) accumulation via autophagy in Alzheimer's disease model.
    Neuroscience. 2020 Oct 15. pii: S0306-4522(20)30656.
    PubMed     Abstract available


    January 2020
  45. MA K, Yu J, Shao W, Xu X, et al
    Functional Overlaps Exist in Neurological and Psychiatric Disorders: A Proof from Brain Network Analysis.
    Neuroscience. 2020;425:39-48.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: